EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol

Giuseppe Lanza iD, Michele Salemi iD, Maria P Mogavero iD, Valentina Catania, Annalisa Galeano, Angelo Garifoli, Bartolo Lanuzza, Manuela Morreale, Mariangela Tripodi, Mariagiovanna Cantone iD, Francesco Cappellani, Carmen Concerto und 4 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0302829 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Giuseppe Lanza und 15 weiteren Autor:innen. Beteiligte Einrichtung: Oasi Research Institute-IRCCS, Troina, Italy. Hauptthemen laut MEDLINE: Restless Legs Syndrome, Transcranial Magnetic Stimulation, Caffeine, Dipyridamole. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Restless Legs Syndrome (RLS) is a common sleep disorder characterized by an urge to move the legs that is responsive to movement (particularly during rest), periodic leg movements during sleep, and hyperarousal. Recent evidence suggests that the involvement of the adenosine system may establish a connection between dopamine and glutamate dysfunction in RLS. Transcranial magnetic stimulation (TMS) is a non-invasive electrophysiological technique widely applied to explore brain electrophysiology and neurochemistry under different experimental conditions. In this pilot study protocol, we aim to investigate the effects of dipyridamole (a well-known enhancer of adenosinergic transmission) and caffeine (an adenosine receptor antagonist) on measures of cortical excitation and inhibition in response to TMS in patients with primary RLS. Initially, we will assess cortical excitability using both single- and paired-pulse TMS in patients with RLS. Then, based on the measures obtained, we will explore the effects of dipyridamole and caffeine, in comparison to placebo, on various TMS parameters related to cortical excitation and inhibition. Finally, we will evaluate the psycho-cognitive performance of RLS patients to screen them for cognitive impairment and/or mood-behavioral dysfunction, thus aiming to correlate psycho-cognitive findings with TMS data. Overall, this study protocol will be the first to shed lights on the neurophysiological mechanisms of RLS involving the modulation of the adenosine system, thus potentially providing a foundation for innovative “pharmaco-TMS”-based treatments. The distinctive TMS profile observed in RLS holds indeed the potential utility for both diagnosis and treatment, as well as for patient monitoring. As such, it can be considered a target for both novel pharmacological (i.e., drug) and non-pharmacological (e.g., neuromodulatory), “TMS-guided”, interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Restless Legs SyndromeTranscranial Magnetic StimulationCaffeineDipyridamoleHumansPilot ProjectsMaleAdenosineAdultFemalePurinergic P1 Receptor AntagonistsMiddle AgedProof of Concept Study

Substanzen

CaffeineDipyridamoleAdenosinePurinergic P1 Receptor Antagonists

Autor:innen und Institutionen

  • Oasi Research Institute-IRCCS, Troina, Italy.
  • Department of Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Division of Neuroscience, San Raffaele Scientific Institute, Sleep Disorders Center, Milan, Italy.
  • Neurology Unit, Policlinico University Hospital "G. Rodolico-San Marco", Catania, Italy.
  • Ophtalomolgy Unit, Policlinico University Hospital "G. Rodolico-San Marco", Catania, Italy.

ORCID-Profile: Giuseppe Lanza, Michele Salemi, Maria P Mogavero, Mariagiovanna Cantone, Alessandro Rodolico, Raffaele Ferri

Förderung

  • Ministero della Salute

Zitieren

APA

Lanza, G., Salemi, M., Mogavero, M. P., Catania, V., Galeano, A., Garifoli, A., Lanuzza, B., Morreale, M., Tripodi, M., Cantone, M., Cappellani, F., Concerto, C., Rodolico, A., Pennisi, M., Bella, R., & Ferri, R. (2024). Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0302829

Vancouver

Lanza G, Salemi M, Mogavero MP, Catania V, Galeano A, Garifoli A, et al. Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol. PLOS ONE. 2024. doi:10.1371/journal.pone.0302829

BibTeX
@article{Lanza2024,
  author = {Lanza, Giuseppe and Salemi, Michele and Mogavero, Maria P and Catania, Valentina and Galeano, Annalisa and Garifoli, Angelo and Lanuzza, Bartolo and Morreale, Manuela and Tripodi, Mariangela and Cantone, Mariagiovanna and Cappellani, Francesco and Concerto, Carmen and Rodolico, Alessandro and Pennisi, Manuela and Bella, Rita and Ferri, Raffaele},
  title = {Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0302829}
}
Kostenlos starten →